Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 2
2005 2
2007 4
2008 3
2010 2
2011 6
2012 7
2013 6
2014 10
2016 5
2017 6
2018 2
2019 1
2020 6
2021 3
2022 6
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
New Treatment Addressing the Pathogenesis of Psoriasis.
Tokuyama M, Mabuchi T. Tokuyama M, et al. Among authors: mabuchi t. Int J Mol Sci. 2020 Oct 11;21(20):7488. doi: 10.3390/ijms21207488. Int J Mol Sci. 2020. PMID: 33050592 Free PMC article. Review.
Secukinumab in plaque psoriasis--results of two phase 3 trials.
Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K, Puig L, Nakagawa H, Spelman L, Sigurgeirsson B, Rivas E, Tsai TF, Wasel N, Tyring S, Salko T, Hampele I, Notter M, Karpov A, Helou S, Papavassilis C; ERASURE Study Group; FIXTURE Study Group. Langley RG, et al. N Engl J Med. 2014 Jul 24;371(4):326-38. doi: 10.1056/NEJMoa1314258. Epub 2014 Jul 9. N Engl J Med. 2014. PMID: 25007392 Free article. Clinical Trial.
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version).
Saeki H, Mabuchi T, Asahina A, Abe M, Igarashi A, Imafuku S, Okubo Y, Komine M, Sano S, Torii H, Morita A, Yotsuyanagi H, Watanabe A, Ohtsuki M; Committee for reviewing the safety of molecularly targeted drugs for psoriasis, Japanese Dermatological Association. Saeki H, et al. Among authors: mabuchi t. J Dermatol. 2023 Feb;50(2):e41-e68. doi: 10.1111/1346-8138.16691. Epub 2022 Dec 29. J Dermatol. 2023. PMID: 36582113
Effectiveness of Long-Term Treatment with Brodalumab on Anxiety or Depressive Symptoms in Japanese Patients with Psoriasis: The ProLOGUE Study.
Ohata C, Kanai Y, Murotani K, Yamazaki F, Takahashi H, Tada Y, Mabuchi T, Mizutani Y, Nomura T, Imafuku S. Ohata C, et al. Among authors: mabuchi t. Dermatol Ther (Heidelb). 2023 Apr;13(4):1039-1052. doi: 10.1007/s13555-023-00909-z. Epub 2023 Mar 6. Dermatol Ther (Heidelb). 2023. PMID: 36877438 Free PMC article.
English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis.
Saeki H, Mabuchi T, Asahina A, Abe M, Igarashi A, Imafuku S, Okubo Y, Komine M, Takahashi K, Torii H, Morita A, Yotsuyanagi H, Watanabe A, Ohtsuki M; Committee for reviewing the safety of molecularly targeted drugs for psoriasis, Japanese Dermatological Association. Saeki H, et al. Among authors: mabuchi t. J Dermatol. 2023 May;50(5):e138-e150. doi: 10.1111/1346-8138.16797. Epub 2023 Apr 1. J Dermatol. 2023. PMID: 37132187
76 results